SMYD3 and neoplasm: SMYD3-driven CDCP1 expression in cancer cells indirectly reprograms neighboring fibroblasts toward a myofibroblastic, pro-tumor phenotype, bridging nuclear epigenetic control with stromal activation [42,43].